SCHEMBL6713656

SCHEMBL6713656

O=C(Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12)c1cccc(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.42
RXFP1 Q9HBX9 2/20 0.40
TP53 P04637 2/20 0.40
MAPT P10636 2/20 0.40
POLB P06746 1/20 0.40
PLCG2 P16885 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
ALDH1A1 P00352 1/20 0.39
PKM P14618 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
STK33 Q9BYT3 2/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
PLA2G7 Q13093 3/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
AKR1C4 P17516 1/20 0.38
AKR1C3 P42330 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710141 0.92 GRIK1 (0.44) GRIK1RXFP1PLCG2STK33PLA2G7
SCHEMBL6712044 0.90 GPR35 (0.46) GRIK1RXFP1TP53MAPTPOLB
SCHEMBL6709929 0.89 GRIK1 (0.49) GRIK1MAPTPLCG2STK33PLA2G7
SCHEMBL6707629 0.89 RXFP1 (0.45) GRIK1RXFP1TP53MAPTPOLB
SCHEMBL6713155 0.88 SERPINE1 (0.48) GRIK1RXFP1MAPTPLCG2NPC1
SCHEMBL6707881 0.88 PARP14 (0.42) GRIK1RXFP1TP53MAPTPOLB
SCHEMBL6709159 0.88 TP53 (0.39) RXFP1TP53MAPTPOLBNPC1
SCHEMBL6710389 0.88 MEN1 (0.40) GRIK1RXFP1PLCG2STK33MEN1
SCHEMBL6709173 0.87 GRIK1 (0.44) GRIK1TP53MAPTPOLBPLCG2
SCHEMBL6709991 0.87 KDR (0.44) GRIK1TP53MAPTPLCG2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885RXFP1 3836/4885TP53 2699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.